Загрузка...
Immune Checkpoint Inhibitors in Advanced-Stage Non-small Cell Lung Cancer
More than half of non-small cell lung cancer (NSCLC) patients are at an advanced stage at the time of diagnosis, and they have a poor prognosis. Systemic treatment is the basic treatment approach for advanced-stage NSCLC, and chemotherapy and targeted treatments are commonly used based on the molecu...
Сохранить в:
| Опубликовано в: : | Turk Thorac J |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Turkish Thoracic Society
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5783068/ https://ncbi.nlm.nih.gov/pubmed/29404172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/TurkThoracJ.2017.17006 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|